Oral formulation containing bone morphogenetic protein for treating metabolic bone disease

摘要

Methods and formulations for the administration of a bone morphogenetic protein (BMP) anywhere along the alimentary canal of an individual are described for use in treating osteoporosis or other metabolic bone diseases.